2023年7月28日 · Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. In one form of pulmonary hypertension, called pulmonary arterial hypertension (PAH), blood vessels in the lungs are narrowed, blocked or destroyed. The damage slows blood flow through the lungs.

2022年7月22日 · Pulmonary arterial hypertension (PAH) is one form of pulmonary hypertension (high blood pressure in your pulmonary arteries). Symptoms may not appear until the condition has gotten worse. Your provider will run many tests to diagnose you and plan your treatment. PAH medications can improve your quality of life and help you live longer.

2023年8月10日 · Having pulmonary arterial hypertension (PAH) means that you have high blood pressure in the arteries that go from your heart to your lungs. It's different from...

2024年10月16日 · Although there is no cure for pulmonary arterial hypertension, there are medications and treatment options that can slow the progression of the disease and improve your quality of life. Studies indicate that early diagnosis is associated with improved survival rates and will help with getting started on the right treatment path.

Pulmonary Arterial Hypertension (PAH) is a syndrome in which the blood pressure in the pulmonary arteries and pulmonary arterioles (the blood vessels located proximal to the capillary bed, the site of oxygen exchange in the lungs) is elevated.

Pulmonary arterial hypertension (PAH), the first category of pulmonary hypertension, is a chronic and progressive disorder characterised by angioproliferative vasculopathy in the pulmonary arterioles, leading to endothelial and smooth muscle proliferation and dysfunction, inflammation and thrombosis.

2025年2月20日 · Pulmonary arterial hypertension (PAH), a condition characterised by progressive obliterative pulmonary vascular remodelling, is a chronic and life-threatening ailment despite advances in treatment. 1,2 Over the past three decades, PAH treatment has primarily targeted the endothelin, nitric oxide, and prostacyclin pathways. 3–5 These treatments have resulted in notable improvements in ...

2018年11月21日 · Pulmonary arterial hypertension (PAH), a pulmonary vascular condition that includes the historic diagnosis of primary pulmonary hypertension (PPH), was once a progressive and fatal disorder for which there was no effective treatment. 1,2 However, in 2019, some forms of PAH are preventable (eg, anorexigen-associated PAH), and other forms of PAH ...

Medications approved to treat pulmonary arterial hypertension (PAH) lead to improvement in functional class, exercise capacity, haemodynamics, right heart function and brain natriuretic peptide (BNP)/N-terminal pro-BNP (NT-proBNP) levels, among others [1–3]. These benefits have been seen in clinical trials across a wide range of PAH ...

2025年3月8日 · Primary pulmonary hypertension (PPH), now known as pulmonary arterial hypertension (PAH), has induced significant treatment breakthroughs in the past decade. Treatment has focused on improving patient survival and quality of life, and delaying disease progression. Current therapies are categorized based on targeting different pathways known to contribute to PAH, including endothelin receptor ...